Status:
UNKNOWN
Trial of Sinphar Lipucan Capsule to Regulate Immune Function
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Nutrition, Healthy
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Trial of Sinphar Lipucan Capsule to regulate immune function
Detailed Description
The immune system is the line of defense for the health of human life entities. If the function decrease, it will reduce the body's defense to outside pathogen and easily lead to the occurrence of dis...
Eligibility Criteria
Inclusion
- \- Healthy Volunteers
Exclusion
- Evidence of chronic cardio-pulmonary disease, immune-suppression or any chronic systemic disease or disability
- Positive pregnancy test or currently breastfeeding
- History of autoimmune disease
- History of allergic rhinitis
- History of physician diagnosed eczema
- Known allergic reaction to Poria cocos or related species,
- Pregnancy or currently breastfeeding.
- History of autoimmune disease or immune disorders.
- History of asthma.
- History of allergic rhinitis.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05329675
Start Date
April 1 2022
End Date
April 30 2025
Last Update
November 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asia University
Taichung, Please Select, Taiwan, 116